Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.050
+0.098 (5.02%)
At close: Jun 27, 2025, 4:00 PM
1.991
-0.059 (-2.88%)
After-hours: Jun 27, 2025, 4:06 PM EDT

Edesa Biotech Stock Forecast

EDSA's stock price has decreased by -52.57% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Edesa Biotech stock ranges from a low of $5.00 to a high of $21. The average analyst price target of $13 forecasts a 534.15% increase in the stock price over the next year.

Price Target: $13.00 (+534.15%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $5.00 $13 $21 $21
Change +143.90% +534.15% +924.39% +924.39%

Analyst Ratings

The average analyst rating for Edesa Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 221112
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 221112

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$5
Strong Buy Initiates $5 +143.90% Jun 27, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$21
Strong Buy Reiterates $21 +924.39% Mar 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$21
Strong Buy Reiterates $21 +924.39% Aug 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$21
Strong Buy Reiterates $21 +924.39% Jun 28, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$21
Strong Buy Reiterates $21 +924.39% Feb 14, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.43
from -1.93
EPS Next Year
-0.57
from -1.43
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Sep 30, 2020 Sep 30, 2021 Sep 30, 2022 Sep 30, 2023 Sep 30, 2024 Sep 30, 2025 Sep 30, 2026 Sep 30, 2027
Revenue
328.80K-------
Revenue Growth
-19.97%-------
EPS
-5.18-7.73-8.37-2.93-1.93-1.43-0.57-0.46
EPS Growth
--------
Forward PE
--------
No. Analysts
-----433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202520262027
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202520262027
High -1.23 -0.59 -0.47
Avg -1.43 -0.57 -0.46
Low -1.60 -0.55 -0.44

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.